Issuer's description of this product:
This is an offering of Class A Shares in Crossgate Capital
Minimum investment
$100.00
This is the minimum amount you would need to put into this in order to invest.
Fixed offer price
Closing date
Ongoing
This offer does not have a closing date and is a continuous issue. It's likely you'll be able to invest for the forseeable future.
Key facts
Provider website
Issuer's industry
Financial/insurance
Fixed offer price details
Key documents
These are the most important documents that a provider is required to file about this investment.
Product disclosure statement
Before you invest in a product like a fund, you are given a PDS which has essential details about it and the company providing it. Here's more on how to read a PDS.
Crossgate_Capital PDS_16 August 2024.pdf
How this investment works, including about the provider, risks, costs and potential returns
Additional disclosure documents
These are more documents from the provider that can contain interesting information.
Crossgate Valuation Policy_25_Jan_19.pdf
Conflicts_of_Interest_and_Related_Parties Policy_CCL (v1).pdf
Crossgate SIPO_25_Jan_19.pdf
Crossgate Management Agreement 25 Jan 19.pdf
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_8 April 19.docx
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_8 April 19.pdf
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_29 April 19.pdf
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_13 May 19.pdf
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_20 May 19.pdf
Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_4 June 19.pdf
Supplementary Document Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_24 June 19.pdf
Director Consent Supplementary Document 24 June 2019.pdf
Director Consent Supplementary PDS July 9 2019.pdf
Supplementary Document -Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_9 July 19 .pdf
Supplementary Document -Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_10 July 19 .pdf
Director Consent Supplementary PDS 10 July 2019.pdf
Supplementary Document -Information incorporated by reference in Product Disclosure Statement for offer of ordinary shares in Crossgate Capital Limited_12 July 19 .pdf
Director Consent Lodge Supplementary PDS July 12 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_29 July 19 .pdf
Director Consent Supplementary PDS 29 July 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_5 August 19 .pdf
Director Cosent Lodge Supplementary PDS August 5 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_13 August 19 .pdf
Director Consent to Lodge Supplementary Document 13 August 2019 .pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_15 August 19 .pdf
Director Consent to Lodge Supplementary Document 15 August 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_26 August 19 .pdf
Director Consent Lodge Supplementary Doc 26 August 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_9 September 19 .pdf
Director Consent Lodge Supplementary PDS 9 Sept 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_23 September 19 .pdf
Director Consent Lodge Supplementary PDS 23 Sept 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_October 7 19 .pdf
Director Consent lodge Supplementary PDS Oct 7 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_October 9 19 .pdf
Director Consent Lodge Supplementary Doc 9 October 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_October 21 19.pdf
Director Consent Lodge Supplementary Doc 21 Oct 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_November 21 19.pdf
Director Consent Lodge Supplementary Doc 21 Nov 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_December 23 19.pdf
Director Consent to Lodge Supplementary Document 23 Dec 2019.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_January 22 2020.pdf
Director Consent Lodge Supplementary Document Jan 22 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_February 3 2020.pdf
Directors Consent to Lodge Supplementary Doc February 3 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_February 10 2020.pdf
Director Consent to Lodge Supplementary Doc February 10 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 9 2020.pdf
Directors Consent to Lodge Supplementary Document March 9 2020.docx.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 25 2020.pdf
Directors Consent to Lodge Supplementary PDS March 25 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited April 8 2020.pdf
Directors Consent to Lodge Supplementary Doc April 8 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited April 22 2020.pdf
Directors Consent to Lodge Supplementary Doc April 22 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 6 2020.pdf
Directors Consent to Lodge Supplementary Document May 6 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 10 2020 .pdf
Director Consent to Lodge Supplementary Document June 10 2020 .pdf
Director Consent to Lodge Supplementary PDS Docuement 25 June 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 25 2020 .pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited September 23 2020 .pdf
Directors Consent to Lodge Supplementary Document Sept 23 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited September 30 2020 .pdf
Director Consent to Lodge Supplementary Docuement Sept 30 2020.pdf
Supplementary PDS -Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 28 2020 .pdf
Directors Consent to Lodge Supplementary Document Oct 28 2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_November 4 2020 .pdf
Director Consent to Lodge Supplementaty Doc Nov 4 2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_November 11 2020 .pdf
Director Consent to lodge Supplementary Doc Nov 11 2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_November 25 2020 .pdf
Director Consent to Lodge Supplementary Document Nov 25 2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_December 2 2020 .pdf
Director Consent to Lodge Supplementary Document 2.12.2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_December 23 2020 .pdf
Directors Consent to Lodge Supplementary Document 23.12.2020.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 3 2021 .pdf
Directors Consent to Lodge Supplementary Document March 3 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 10 2021 .pdf
Directors Consent to lodge Supplementary Document March 10 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 17 2021 .pdf
Director Consent to Lodge Supplementary Document 17 March 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 24 2021 .pdf
DIrector Consent to Lodge Supplementary PDS 24 March 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_March 31 2021 .pdf
Directors Consent to Lodge Supplementary PDS March 31.2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_April 7 2021 .pdf
Directors Consent to Lodge Supplementary Document 7 April 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_April 14 2021 .pdf
Directors Consent to Lodge Supplementary Doc April 14 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited_April 21 2021 .pdf
Directors Consent to Lodge Supplementary Document April 21 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 5 May 2021 .pdf
Directors Consent to Lodge Supplementary Document 5 May 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 12 May 2021 .pdf
Directors Consent to Lodge Supplementary Document 12 May 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 16 June 2021 .pdf
Director Consent to Lodge Supplementary Document 16 June 2021.pdf
Crossgate Capital_Annual Review_2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 23 June 2021 .pdf
Director Consent to Lodge Supplementary Document 23 June 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 30 June 2021 .pdf
Director Consent to Lodge Supplementary Document 30 June 2021 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 14 July 2021 .pdf
Directors Consent to Lodge Supplementary Document 14 July 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 18 August 2021 .pdf
Director Consent to Lodge Supplementary Document 18 Aug 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 25 August 2021 .pdf
Directors Consent to Lodge Supplementary Document 25 Aug 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 1 Sept 2021 .pdf
Director Consent to Lodge Supplementary Document Sept1 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 8 Sept 2021 .pdf
Director Consent to Lodge Supplementary Document Sept 8 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 15 Sept 2021 .pdf
Director Consent to Lodge Supplementary Document Sept 15 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 22 Sept 2021 .pdf
Director Consent to Lodge Supplementary Document Sept 22 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 29 Sept 2021 .pdf
Director Consent to Lodge Supplementary Document Sept 29 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 6 Oct 2021 .pdf
Directors Consent to Lodge Supplementary Document 6 Oct 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 10 Nov 2021 .pdf
Director consent to lodge Supplementary Doc 10 Nov 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 17 Nov 2021 .pdf
Director Consent to Lodge Supplementary Doc 17 Nov 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 26 Nov 2021 .pdf
Directors Consent to Lodge Supplementary Document 26 November 2021.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 12 January 2022 .pdf
Directors Consent to Lodge Supplementary Document 12 January 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 19 January 2022 .pdf
Directors Consent to Lodge Supplementary Document 19 January 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 26 January 2022 .pdf
Directors Consent to Lodge SupplementaryDocument 26 January 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 2 February 2022 .pdf
Director Consent to Lodge Supplementary Document 2 Feb 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 10 February 2022 .pdf
Director Consent to Lodge Supplementary Document 10 Feb 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 16 February 2022 .pdf
Director Consent to Lodge Supplementary Document 16 Feb 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 23 February 2022 .pdf
Director Consent to Lodge Supplementary Document 23 Feb 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 2 March 2022 .pdf
Director consent to lodge Supplementary Doc 2 March 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 9 March 2022 .pdf
Director consent to lodge Supplementary Doc 9 March 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 16 March 2022 .pdf
Director consent to lodge Supplementary Doc 16 March 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 23 March 2022 .pdf
Director consent to lodge Supplementary Doc March 23 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 30 March 2022 .pdf
Director Consent to Lodge Supplementary Doc March 30 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 6 April 2022 .pdf
Directors Consent to Lodge Supplementary Document 6 April 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 13 April 2022 .pdf
Directors Consent to Lodge Supplementary Document 13 April 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited 18 May 2022 .pdf
Directors consent to lodge Supplementary Document May 18 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 1 2022 .pdf
Directors Consent to lodge Supplementary PDS 1 June 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 9 2022 .pdf
Directors Consent to Lodge Supplementary Document June 9 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 15 2022 .pdf
Directors consent to Lodge Supplementary Document 15 June 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 22 2022 .pdf
Directors consent to Lodge Supplementary Document 22 June 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 13 2022 .pdf
Directors Consent to lodge Supplementary Document July 13 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 20 2022 .pdf
Director Consent to lodge Supplementary Document 20 July 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 27 2022 .pdf
Director Consent to Lodge Supplementary Document 27 July 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 3 2022 .pdf
Directors Consent to Lodge Supplementary Document 3 August 22.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited September 7 2022 .pdf
Directors Consent to Lodge Supplementary Document Sept 7 2022.pdf
Directors Consent to lodge Supplementary PDS Doc Oct 12 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 12 2022 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited November 16 2022 .pdf
Directors Consent to Lodge Supplementary Doc 16 Nov 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 7 2022 .pdf
Directors consent to lodge Supplementary Doc Dec 7 2022.pdf
Directors Consent to lodge Supplementary Doc Dec 14 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 14 2022 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 21 2022 .pdf
Directors consent to lodge Supplementary Doc Dec 21 20221.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 30 2022 .pdf
Director consent to lodge Supplementary Document Dec 30 2022.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 11 2023 .pdf
Directors consent to lodge Supplementary Doc Jan 11 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 18 2023 .pdf
Directors consent to lodge Supplementary Doc 18 Jan 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 25 2023 .pdf
Directors consent to lodge Supplementary Doc Jan 25 2033.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited February 1 2023 .pdf
Director consent to lodge Supplementary Doc Feb 1 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited February 9 2023 .pdf
Directors consent to lodge Supplementary Doc Feb 9 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited February 22 2023 .pdf
Directors Consent to lodge Supplementarty Doc Feb 22 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 3 2023 .pdf
Director consent to lodge Supplementary Doc 3 May 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 17 2023 .pdf
Director consent to lodge Supplementary Doc 17 May 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 31 2023 .pdf
Director consent to lodge Supplementary Doc 31 May 2023.pdf
Directors consent to lodge Supplementary Doc 14 June 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 14 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 21 2023 .pdf
Directors consent to lodge Supplementary Doc 21 June 2023.pdf
Directors consent to lodge Supplementary Doc 28 June 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 28 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 12 2023 .pdf
Directors consent to lodge Supplementary Doc 12 July 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 19 2023 .pdf
Directors consent to lodge Supplementary Doc 19 July 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 24 2023 .pdf
Director Consent to lodge Supplementary Document July 24 2023.pdf
Crossgate_Management Agreement_24 July 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 26 2023 .pdf
Directors consent to lodge Supplementary Doc 26 July 2023.pdf
Director consent to lodge Supplementary Doc 9 August 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 9 2023 .pdf
Director consent to lodge Supplementary Doc August 23 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 23 2023 .pdf
Director consent to lodge Supplementary Doc September 6 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Sept 6 2023 .pdf
Director consent to lodge Supplementary Doc September 20 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Sept 20 2023 .pdf
Directors consent to lodge Supplementary Doc 4 October 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Oct 4 2023 .pdf
Director consent to lodge Supplementary Doc November 15 2023.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Nov 15 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Nov 22 2023 .pdf
Director consent to lodge Supplementary Doc November 22 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Nov 29 2023 .pdf
Director consent to lodge Supplementary Doc November 29 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Dec 20 2023 .pdf
Directors consent to lodge Supplementary Doc December 20 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited Dec 29 2023 .pdf
Directors consent to lodge Supplementary Doc December 29 2023 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 10 2024 .pdf
Director consent to lodge Supplementary Doc January 10 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 17 2024 .pdf
Director consent to lodge Supplementary Doc January 17 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited January 24 2024 .pdf
Director consent to lodge Supplementary Doc January 24 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited February 8 2024 .pdf
Director consent to lodge Supplementary Doc February 8 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited February 21 2024 .pdf
Director consent to lodge Supplementary Doc February 21 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited March 6 2024 .pdf
Director consent to lodge Supplementary Doc March 6 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited March 20 2024 .pdf
Director consent to lodge Supplementary Doc March 20 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited April 4 2024 .pdf
Director consent to lodge Supplementary Doc April 4 2024.pdf
Director consent to lodge Supplementary Doc April 17 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited April 17 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 1 2024 .pdf
Director consent to lodge Supplementary Doc May 1 2024.pdf
Director consent to lodge Supplementary Doc May 15 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 15 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 22 2024 .pdf
Director consent to lodge Supplementary Doc May 22 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited May 29 2024 .pdf
Director consent to lodge Supplementary Doc May 29 2024.pdf
Directors Consent to Lodge Supplementary Document June 12 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 12 2024 .pdf
Directors Consent to Lodge Supplementary Document June 19 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 19 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited June 26 2024 .pdf
Directors Consent to Lodge Supplementary Document June 26 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 10 2024 .pdf
Director consent to lodge Supplementary Doc July 10 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 17 2024 .pdf
Director consent to lodge Supplementary Doc July 17 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited July 24 2024 .pdf
Director consent to lodge Supplementary Doc July 24 2024.pdf
Directors Consent to Lodge Supplementary Document August 7 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 7 2024 .pdf
Directors Consent to Lodge Supplementary Document August 16 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 16 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited August 21 024 .pdf
Directors Consent to Lodge Supplementary Document August 21 2024.pdf
Directors Consent to Lodge Supplementary Document September 4 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited September 4 2024 .pdf
Directors Consent to Lodge Supplementary Document September 18 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited September 18 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 2 2024 .pdf
Directors Consent to Lodge Supplementary Document October 2 2024.pdf
Directors Consent to Lodge Supplementary Document October 16 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 16 2024 .pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 23 2024 .pdf
Directors Consent to Lodge Supplementary Document October 23 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited October 31 2024 .pdf
Directors Consent to Lodge Supplementary Document October 31 2024.docx
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited November 27 2024 .pdf
Directors Consent to Lodge Supplementary Document November 27 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 11 2024 .pdf
Directors Consent to Lodge Supplementary Document December 11 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 18 2024 .pdf
Directors Consent to Lodge Supplementary Document December 18 2024.pdf
Supplementary PDS_Information incorporated by reference in Product Disclosure Statement Crossgate Capital Limited December 27 2024 .pdf
Directors Consent to Lodge Supplementary Document December 27 2024.pdf
Additional details
Issuer details
Name
CROSSGATE CAPITAL LIMITED
Type
NZ Limited Company
Industry
Financial/insurance
Website
NZBN
9429046932211
FSP Number
Credit rating
Not provided
Offer details
Date registered
28 January 2019
Date opened
15 March 2024
Closing date
None
Continuous issue
Yes
Further payments may be required
No
Restrictions on transfer
No
Restrictions on acquisition
No
Convertible product
No
Intending to list
No
Schedule 1 exemption
No
FMA exemption
No
Reference numbers
Offer
OFR12554: CROSSGATE CAPITAL
Next steps
Want to know more about this investment or how it compares to others? Have a look at its peers.
Product disclosure statement
Take a deeper dive into the PDS, which has essential details about this offer and the company providing it. Here's more on how to read a PDS.
Getting investment advice
Good advice is gold. Everyone can benefit from expert advice, provided the adviser has your interests at heart. Here's how to find one and key questions to ask.
Interested in investing in this offer? Visit the provider's website. crossgatecapital.co.nz